Cognitive
Noopept
Also called Omberacetam, GVS-111
per administration
It has been used in people, but no trial has settled how much or how often.
Licensed as a medicine in Russia.
The human evidence for Noopept used the oral route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Work out your draw
These numbers are a starting point — change any of them.
- Concentration
- 3.33mg/mL
- Volume per draw
- 3mL
- Units to dial
- 300
- Doses per cartridge
- 1
This is 300 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.
Dial range varies by pen; 1–60 units is the common configuration.
Vial label
Copy this into your label printer.
Published research contexts for Noopept describe 10–30 mg per administration. Descriptive only, not a recommendation.
Cleared quickly after oral administration; roughly 15–30 minutes in plasma.
Licensed as a medicine in Russia and taken by mouth, not injected — an oral nootropic dipeptide derivative usually dosed at about 10 mg two to three times a day (10–30 mg total). Because it is swallowed rather than reconstituted, the vial size shown is nominal, and no injectable dose-ranging schedule exists, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 2hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Russian Noopept (GVS-111) literatureAn orally active proline-containing dipeptide nootropic studied largely in Russian-language clinical and preclinical work.